NEW YORK (360Dx) – The topsy-turvy broader markets dragged down the shares of most diagnostics company in February as the 360Dx Index slid 3 percent compared to January.

The index still outpaced the Dow Jones Industrial Average, which declined 4 percent month over month, and the Nasdaq Composite, which was down 5 percent, but lagged behind the Nasdaq Biotech, which fell 2 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.